US/UK/Canada

Share

Pick a time period -
Tags ( Active)

Oncopeptides has announced the Nomination Committee

STOCKHOLM — December 22, 2022 — Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO). According to the principles for the appointment of the Nomination Committee in Oncopeptides AB (publ), the Nomination Committee for the annual general meeting 2023 shall be composed of members appointed by the three largest shareholders in terms of voting rights as of September 30 who are willing to participate in the Nomination Committee, along with the Chairman of the Board of Directors.The composition of the Nomination Committee has now been established, and Oncopeptides today announced that the Nomination

Oncopeptides has announced the Nomination Committee

STOCKHOLM — November 12, 2021 — Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO). According to the principles for the appointment of the Nomination Committee in Oncopeptides AB (publ), the Nomination Committee for the annual general meeting 2022 shall be composed of members appointed by the three largest shareholders in terms of voting rights as of September 30, along with the Chairman of the Board of Directors.The composition of the Nomination Committee has now been established, and Oncopeptides today announced that the Nomination Committee in respect of the annual general meeting 2022

Nomination committee in Oncopeptides established

STOCKHOLM — October 21, 2020 — Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), today announced that the composition of the Nomination Committee for the Annual General Meeting 2021 has been established. The Nomination Committee consists of the following persons who together represent approximately 34 percent of the number of shares and votes in the company, based on the shareholder information by the end of September;· Staffan Lindstrand, appointed by HealthCap VI L.P. · Patrik Sobocki, appointed by Stiftelsen Industrifonden · Ulrik Grönvall, appointed by Swedbank Robur Fonder ·

Nomination Committee appointed in respect of AGM 2020 in Oncopeptides

Stockholm - October 10, 2019 - According to the principles for the appointment of the Nomination Committee in Oncopeptides AB adopted at the annual general meeting held on May 21st, 2019, the Nomination Committee for the annual general meeting 2020 shall be composed of members appointed by the three largest shareholders in terms of voting rights as of September 30th, along with the Chairman of the Board of Directors.The composition of the Nomination Committee has now been established, and Oncopeptides today announced that the Nomination Committee in respect of the annual general meeting

Nomination Committee appointed in respect of AGM 2019 in Oncopeptides

Stockholm - October 15, 2018 - According to the principles for the appointment of the Nomination Committee in Oncopeptides AB adopted at the annual general meeting held on 17 May 2018, the Nomination Committee for the annual general meeting 2019 shall be composed of members appointed by the three largest shareholders in terms of voting rights as of 28 September, along with the Chairman of the Board of Directors.The composition of the Nomination Committee has now been established, and Oncopeptides today announced that the Nomination Committee in respect of the annual general meeting 2019

There are no items matching the current filter
There are no more items matching the current filter
Back to top

Subscribe

Media